Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
GLP-1R agonist DMB
Cat. No.:
OB0225LY-0268
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
GLP-1R agonist DMB is a potent GLP-1 receptor agonist that mimics the biological activity of natural GLP-1.
Synonym:
281209-71-0; N-(tert-Butyl)-6,7-dichloro-3-(methylsulfonyl)quinoxalin-2-amine; GLP-1R agonist; GLP-1R agonist 2; N-tert-Butyl-6,7-dichloro-3-methylsulfonylquinoxalin-2-amine
CAS No.:
281209-71-0
Compound CID:
16007289
Formula:
C13H15Cl2N3O2S
Formula Weight:
348.25
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
GLP-1R agonist DMB can be used to study the role of glucagon-like peptide-1 in metabolic regulation or play an important role in models of diabetes and related metabolic diseases.
Library Information
Targets:
Glucagon receptor
Receptors:
GLP-1
Pathways:
GPCR/G protein
Plate Number:
AOCL-4
Plate Location:
d7
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
9 mg/mL; 25.8 mM
